Volume 32 Issue 3, March 2019

Detection of driver mutations in BRAF can aid in diagnosis and early treatment of dedifferentiated metastatic melanoma

• Nasr Alrabadi
• Natasha Gibson
• Ahmed K. Alomari

BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor

• George Jour
• Varshini Vasudevaraja
• Phyu P. Aung

Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery

• Vanda F. Torous
• Stuart J. Schnitt

Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity

• Beth Z. Clark
• Agnieszka Onisko
• David J. Dabbs

Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients

• Hyojin Kim
• Hyun Jung Kwon
• Jin-Haeng Chung

Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations

• David B. Chapel
• Aliya N. Husain
• Thomas Krausz

The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis

• Rongbei Liu
• Mengyu Wang
• Zhinong Jiang

Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes

• Suzanne Crumley
• Katherine Kurnit
• Russell Broaddus

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients

• Ana M. Bolivar
• Rajyalakshmi Luthra
• Russell R. Broaddus

Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma

• Sigrid Regauer
• Karl Kashofer
• Olaf Reich

Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases

• Alyaa Al-Ibraheemi
• Andrew L. Folpe
• Fredrik Mertens

H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features

• Naohiro Makise
• Masaya Sekimizu
• Akihiko Yoshida

Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms

• Anthony P. Martinez
• Karen J. Fritchie
• Andrew L. Folpe

United States & Canadian Academy of Pathology 108th Annual Meeting Abstracts: Unlocking Your Ingenuity